NVS (NVS)

Latest stories mapped to NVS

Everything Newsig has mapped to NVS, newest first — no importance filter. Topic pages list critical and high-importance stories only.

• 2026-09-22 Lantheus gains approval of Bravnesta, generic competitor to Lutathera
• 2026-09-22 European drugmakers call for faster trials, more spending to compete with US, China
• 2026-09-18 Novartis (NVS) Suffers its Third Drug Trial Setback in a Week, and its Worst Trading Day in Years
• 2026-09-17 Novartis (NVS) and Ionis (IONS)’ Big Cholesterol Bet Comes Up Short in Late-Stage Trial
• 2026-09-16 Novartis scraps ALS therapy after mid-stage trial setback
• 2026-09-15 Novartis' Lutathera now facing generic competition from Cirium's Bexlutry
• 2026-09-13 Novartis (NVS) Just Handed Monte Rosa (GLUE) A $50M Milestone
• 2026-09-11 Novartis: More Pain on the Way?